An international team spearheaded by researchers at º«¹úÂãÎè has discovered a biological mechanism that could explain heightened somatic awareness, a condition where patients experience physical discomforts for which there is no physiological explanation.


Female health researchers who applied for grants from Canada's major health research funder were funded less often than male counterparts because of potential bias, and characteristics of peer reviewers can also affect the result, found a study in the .
Applicants who had not been previously funded also received lower scores, making them less likely to be funded.

Practice might not always make perfect, but it’s essential for learning a sport or a musical instrument. It's also the basis of brain training, an approach that holds potential as a non-invasive therapy to overcome disabilities caused by neurological disease or trauma.
Research at the Montreal Neurological Institute and Hospital of º«¹úÂãÎè (The Neuro) has shown just how adaptive the brain can be, knowledge that could one day be applied to recovery from conditions such as stroke.

Canadian discovery may soon lead to the prevention of cardiac fibrosis
Groundbreaking research from the University of Alberta and º«¹úÂãÎè has opened the door towards the future prevention of cardiac fibrosis—a condition leading to heart failure for which there is currently no treatment.

The potential of light as a non-invasive, highly-focused alternative to pain medication was made more apparent thanks to research conducted by scientists at the Montreal Neurological Institute and Hospital of º«¹úÂãÎè and the º«¹úÂãÎè Health Centre.

º«¹úÂãÎè Newsroom
Canadian drug safety network provides reassuring evidence regarding risk of heart failure of anti-diabetes medications
Incretin-based drugs, a type of medication used to treat type 2 diabetes, do not increase the risk of being hospitalized for heart failure relative to commonly used combinations of oral anti-diabetic drugs, according to a new study published in the New England Journal of Medicine.

By Chris Chipello, º«¹úÂãÎè Newsroom
Surprisingly complex interactions between neurotransmitter receptors and other key proteins help explain the brain’s ability to process information with lightning speed, according to a new study.

It is estimated that half of all cancer patients suffer from a muscle wasting syndrome called cachexia. Cancer cachexia impairs quality of life and response to therapy, which increases morbidity and mortality of cancer patients. Currently, there is no approved treatment for muscle wasting but a new study from the Research Institute of the º«¹úÂãÎè Health Centre (RI-MUHC) and University of Alberta could be a game changer for patients, improving both quality of life and longevity. The research team discovered a new gene involved in muscle wasting that could be a good target for drug development.

New research released today in Nature Neuroscience reveals for the first time that pain is processed in male and female mice using different cells. These findings have far-reaching implications for our basic understanding of pain, how we develop the next generation of medications for chronic pain—which is by far the most prevalent human health condition—and the way we execute basic biomedical research using mice.